Aktis Oncology
$607.2M
Targeted radiopharmaceuticals for solid tumors
- $607.2M last priced transaction (>1yr old) (as of 2024-09)
- 10 sourced signals across 2 data sources
Loading the full interactive profile on VizierAtlas…
Targeted radiopharmaceuticals for solid tumors
Loading the full interactive profile on VizierAtlas…